港股医药股延续涨势 博安生物涨近9%

Group 1 - The core viewpoint of the article highlights the continued upward trend of Hong Kong pharmaceutical stocks, with specific companies showing significant gains [1] - Bohan Bio (06955.HK) experienced an increase of 8.96%, indicating strong market performance [1] - Other notable performers include Yiming Anke-B (01541.HK) with a rise of 7.67%, Tiger Med (03347.HK) up by 5.32%, and Zhaoyan New Drug (06127.HK) increasing by 5.41% [1]